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BACKGROUND: Endometrial cancer is the most common gynaecological malignancy in the United Kingdom. Diagnosis currently involves
subjective expert interpretation of highly processed tissue, primarily using microscopy. Previous work has shown that infrared (IR)
spectroscopy can be used to distinguish between benign and malignant cells in a variety of tissue types.
METHODS: Tissue was obtained from 76 patients undergoing hysterectomy, 36 had endometrial cancer. Slivers of endometrial tissue
(tumour and tumour-adjacent tissue if present) were dissected and placed in fixative solution. Before analysis, tissues were thinly
sliced, washed, mounted on low-E slides and desiccated; 10 IR spectra were obtained per slice by attenuated total reflection Fourier-
transform IR (ATR-FTIR) spectroscopy. Derived data was subjected to principal component analysis followed by linear discriminant
analysis. Post-spectroscopy analyses, tissue sections were haematoxylin and eosin-stained to provide histological verification.
RESULTS: Using this approach, it is possible to distinguish benign from malignant endometrial tissue, and various subtypes of both.
Cluster vector plots of benign (verified post-spectroscopy to be free of identifiable pathology) vs malignant tissue indicate the
importance of the lipid and secondary protein structure (Amide I and Amide II) regions of the spectrum.
CONCLUSION: These findings point towards the possibility of a simple objective test for endometrial cancer using ATR-FTIR
spectroscopy. This would facilitate earlier diagnosis and so reduce the morbidity and mortality associated with this disease.
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Attenuated total reflection Fourier-transform infrared (ATR-FTIR)
spectroscopy allows the objective classification of biological
material on a molecular level. Previous studies have shown the
potential of vibrational spectroscopy in categorising cancer and
intraepithelial neoplasia in tissues such as the cervix, prostate, and
various parts of the gastrointestinal tract (Sindhuphak et al, 2003;
German et al, 2006; Maziak et al, 2007; Walsh et al, 2008; Baker
et al, 2009; Sahu et al, 2010). Many of these tissues are classified
and analysed as either normal or abnormal. In contrast, human
endometrium is a tissue that exhibits biological plasticity, capable
of adopting several different histological conformations depending
on the hormonal milieu.
Endometrial cancer is the most common gynaecological
malignancy in the United Kingdom. This is most likely to be
related to the increasing prevalence of obesity among women
(Renehan et al, 2008). Adipose tissue contains the enzyme
aromatase, responsible for the conversion of the adrenal-derived
androgen androstenedione to oestrone, an oestrogen. This acts
unopposed by progesterone to stimulate endometrial proliferation
in perimenopausal and postmenopausal women (Schindler, 2009).
Oestrone also appears to exert genotoxic effects (Yared et al,
2002). Endometrial cancer is frequently underestimated as a fairly
benign condition. Indeed, early, low-grade disease has an excellent
prognosis; however, a significant minority of patients are less
fortunate and have advanced or high-grade disease (Uharcek,
2008).
Endometrial cancers are classified according to their behaviour
and histological appearance into two groups. Endometrioid
cancers are often referred to as type I disease. They are associated
with obesity, polycystic ovarian syndrome, unopposed oestrogen
hormone replacement therapy, and the perimenopausal age group.
All of these factors contribute to a relative oestrogen excess
(Bokhman, 1983). Endometrioid cancers are graded 1–3 according
to the proportion of solid tissue within the tumour, with grade 3
containing the least glandular tissue and being the most aggressive
(Horn et al, 2007). Type II endometrial cancers include the
uterine serous and clear cell subtypes. These are found in older
postmenopausal women, are unconnected with oestrogen, and
behave in a more aggressive manner. Carcinosarcomas are
frequently included in this category; however, their true relation
to other uterine cancer subtypes is uncertain (D’Angelo and Prat,
2010). Type I and II endometrial cancers have different mutation
profiles and precursor lesions (Sherman, 2000; Fadare and Zheng,
2008).
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of the electromagnetic spectrum (Martin et al, 2010). Attenuated
total reflection Fourier-transform IR spectroscopy exploits this
property, measuring the absorbance of IR within this region.
Each individual chemical bond has its own vibrational charac-
teristics, causing it to absorb IR at a particular frequency (usually
expressed as wavenumber¼1/wavelength). Plotting wavenumber
against intensity of absorbance generates a spectrum that
represents the quantity and type of bonds present within the
material examined. When applied to biological material this
distinctive pattern is known as the ‘biochemical-cell fingerprint’.
Changes in the type, conformation, or quantity of bonds generate
different spectra; this could be used to differentiate between
benign and malignant tissues. Powerful computational data
reduction and separation techniques are required to interpret the
vast quantity of data generated (Martin et al, 2007). Here, principal
component analysis (PCA) followed by linear discriminant
analysis (LDA) has been used. Principal component analysis
identifies variance and compresses the data. Linear discriminant
analysis demonstrates separation between different categories
such as histological types. Combined together, these two tech-
niques reveal the chemical bonds that are most important in such
separation.
In previous work, transmission FTIR microspectroscopy was
applied using a synchrotron source to de-waxed paraffin-
embedded endometrial tissue (Kelly et al, 2009). For endometrial
spectroscopy to have a practical application, it must be simple and
function without the need for a particle accelerator. Attenuated
total reflection Fourier-transform IR spectroscopy fulfils these
requirements. This is the first description of ATR-FTIR spectro-
scopy in endometrial tissue and addresses the potential applica-
tions of this technique in the future.
PATIENTS AND METHODS
Study participants
Informed consent to take endometrial tissue for use in research
was obtained from women undergoing hysterectomy. Ethical
committee approval was obtained (LREC no. 05/Q1302/83;
Preston, Chorley and South Ribble Ethical Committee). Patients
were allocated study numbers based on their preoperative
diagnostic category. In total, 101 endometrial samples were
obtained from 76 patients, 36 of whom had endometrial cancer
(see Table 1). The indications for hysterectomy in the benign
group included bleeding problems (dysfunctional uterine bleeding,
n¼6), pelvic mass (fibroids, n¼6; ovarian mass, n¼7), pelvic
pain (endometriosis, n¼4; adenomyosis, n¼6; endometriosis and
adenomyosis, n¼2), premalignant disease (cervical intraepithelial
neoplasia, n¼2; suspected hyperplasia, n¼2), and prophylaxis
(previous breast cancer, n¼5).
Tissue preparation
After surgical resection, unfixed hysterectomy specimens were
transported directly to the pathology laboratory. Here, a con-
sultant histopathologist dissected out a sliver of endometrial tissue.
If the uterus contained tumour, a piece of this was sampled
together with a piece of adjacent macroscopically benign
endometrium (if present); otherwise, a representative piece of
endometrium was chosen. Tissue samples were then placed in
Surepath cytology medium. The time from removal of the uterus
from the patient to placement of the sample in fixative was
o20min.
All samples were stored in Surepath at room temperature for
between 48h and 4 weeks. After fixation, tissue samples were
thinly sliced (p1-mm thick/slice) by hand using a Stadie–Riggs
platform and Thomas blade (Martin and McLean, 1995). Two slices
were prepared from each endometrial specimen. The tissue
samples were orientated so that the first slice consisted of the
surface of the endometrium and the second, the tissue immediately
below. Each slice was washed in three separate 10-ml volumes of
distilled H2O. Slices were mounted on low-E reflective glass slides
and placed in a desiccator for a minimum of 48h. An overview of
the methodology is shown in Figure 1.
Attenuated total reflection Fourier-transform infrared
spectroscopy
Infrared spectra were obtained using a Bruker Vector 22 FTIR
spectrometer with Helios ATR attachment containing a diamond
crystal (Bruker Optics Ltd, Coventry, UK); 10 spectra were
acquired per slide, each from a different area of the tissue slice.
The ATR crystal was cleaned with dry tissue paper between each
spectra acquisition, and a background reading was taken prior to
each new slide. A cut-off value for the Amide I peak was designated
as 0.12, to ensure spectral quality (Trevisan et al, 2010). Spectra
were cut to between 1800 and 900cm
 1, baseline corrected and
normalised to Amide I (1650cm
 1). Because of the non-destructive
nature of this bio-analytical approach, the post-spectroscopy
sections were then stained with haematoxylin and eosin (H&E).
Macroscopically normal endometrium sometimes contains impor-
tant lesions (intraepithelial carcinoma, subtle areas of hyper-
plasia, and carcinoma restricted to the endometrium) identifiable
under the microscope. It is not possible to totally validate a
tissue as normal or benign; however, this allowed histological
categorisation and verification of the tissue sections analysed in
this study.
Table 1 Hierarchical classification system and subgroup numbers as
spectra, samples, and patients
Tissue classification Spectra (n) Samples (n) Patients (n)
Normal
Premenopausal
Proliferative 250 25 13
Early secretory 80 8 4
Mid secretory 20 2 1
Late secretory 60 6 3
Menstrual 61 6 3
On progesterone 50 5 3
Postmenopausal
Atrophic 219 22 11
Other 40 4 2
Cancer
Endometrioid
Grade 1 179 18 9
Grade 2 140 14 7
Grade 3 140 14 7
Non-endometrioid
Uterine serous 60 6 3
Clear cell 20 2 1
Mixed 40 4 2
Carcinosarcoma 80 8 4
Adenosarcoma 40 4 2
Tumour adjacent
Endometrioid (adjacent)
Atrophic 240 24 12
Hyperplasia 80 8 4
Non-endometrioid (adjacent)
Atrophic 200 20 10
Hyperplasia 0 0 0
Abbreviation: n¼number.
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Multivariate analysis was performed with PCA followed by LDA
using MATLAB R2008a software (The Mathworks Inc., Natick,
MA, USA). Principal component analysis was used for preliminary
data reduction and to demonstrate variance in an unsupervised
manner. Linear discriminant analysis derives vectors from the
principal components (PCs) and so minimises the within-category
differences (which would mostly be associated with typical
heterogeneity in any tissue sample) while maximising between-
category discriminating characteristics (i.e., those most likely to be
diagnostic). This allows separation between groups to be visualised
more clearly. Multivariate analysis results are visualised in two
different ways: scores plots and cluster vector plots. Scores plots
are scatter charts drawn using the data values obtained after PCA–
LDA (i.e., the ‘scores’) as Cartesian coordinates. Cluster vector
plots are ‘pseudo-spectra’ (in the sense that as spectra, they
contain values per wavenumber, although they contain coefficients
of linear combinations) obtained by the following construction:
each cluster vector is associated with a different histology type, it
corresponds exactly to the vector that points from the mean
spectrum of a reference histology type to mean spectrum from its
specific histology type (Martin et al, 2007; Llabjani et al, 2010).
This construction is done inside the vector space spanned after the
PCA–LDA data reduction. These techniques were applied to total
spectra per slide. All wavenumbers are rounded down to the
nearest whole number.
RESULTS
Principal component analysis–LDA of the biochemical-
cell-fingerprint region (1800–900cm
 1) was used to derive scores
plots and corresponding cluster vector plots for several combina-
tions of tissue types. Principal component analysis–LDA scores
plots display each spectrum as a point in multidimensional space
(number of dimensions is determined by n 1, where n is the
number of groups being compared) with proximity implying
spectral, and therefore biochemical, similarity. The cluster vector
plots also display variance, but here it is shown as the difference
between one group (plotted as the baseline) as compared with all
other groups at all wavenumbers.
Tracking normal tissue through the menstrual cycle
Normal endometrium, obtained from premenopausal women, was
classified by the histological phase of the menstrual cycle.
Clustering within and separation between most phases was
observed. This was most clearly visible after rotation of the
three-dimensional (3D) plot (Figure 2A). Clear separation is seen
between the three subgroups of secretory endometrium. Proli-
ferative phase endometrium and menstrual phase endometrium
did not separate. The cluster vector plot shown in Figure 2B uses
proliferative endometrium as the baseline and all others are
compared with this. The phases adjacent to the proliferative phase
in the cycle (menstrual and early secretory) are the most
biochemically similar to it. Late secretory endometrium exhibits
large peaks in the lipid (1743cm
 1), Amide I (1624cm
 1), Amide
II (1519cm
 1), and asymmetric phosphate stretching vibrations
(nasPO2
  (1203cm
 1)) regions. Mid-secretory endometrium also
has prominent peaks in the lipid region (1735cm
 1), Amide I
(1666, 1627, 1597cm
 1), Amide II (1516cm
 1), other protein
regions (1481, 1435cm
 1), nasPO2
  (1215cm
 1), and symmetric
phosphate stretching vibrations (nsPO2
  (1095cm
 1)) regions. The
largest peak is at 1026cm
 1; this corresponds with glycogen,
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Figure 1 Diagrammatic representation of methodology.
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Figure 2 Comparison of normal premenopausal endometrial tissue
subtypes through the menstrual cycle. (A) Rotated scores plot. (B) Cluster
vector plot (proliferative tissue as comparator).
Infrared spectroscopy in benign and malignant endometrium
SE Taylor et al
792
British Journal of Cancer (2011) 104(5), 790–797 & 2011 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sa biochemical substrate known to be present at high levels in mid-
secretory endometrium (Robles et al, 1972).
Benign tissue vs cancer
Benign and malignant endometrial tissues were compared. The
benign group consisted of tissues from all the women recruited to
the study who did not have endometrial cancer. After spectroscopy
analyses, these tissue sections were H&E-stained; in all cases, the
designated tumour sections contained cytological atypia and
altered tissue architectural characteristics, whereas the designated
benign sections appeared normal, although postmenopausal
tissues typically showed an absence of glandular elements. The
tumour tissues were subdivided into endometrioid cancer and
non-endometrioid cancer. Figure 3A shows the scores plot for
these three categories. There is a degree of overlap between
them, but B80% of separation between benign and malignant
spectra can be achieved by drawing a line perpendicular to LD1,
near the point of origin. Figure 3B shows the cluster vectors of the
two malignant classes vs benign tissue. The majority of the
difference between benign and malignant tissue lies in the lipid
(1735cm
 1) and Amide I/II (1624, 1570, 1516cm
 1) regions of the
spectra, although there are also important contributions from a
protein band (1477cm
 1), nasPO2
  (1230cm
 1), RNA/carbohydrate
(1168cm
 1), and phosphorylated proteins (968cm
 1).
Endometrioid cancers and non-endometrioid cancers are
spectrally similar between 1500 and 900cm
 1 as the cluster vector
plots exhibit similar patterns, although several peaks are shifted by
a few wavenumbers. Both have peaks at around 1450cm
 1, with
further peaks at 1230cm
 1 (nasPO2
 ) and 1168cm
 1 (RNA/
carbohydrate). Between 1800 and 1500cm
 1, the vectors differ in
magnitude of absorbance, with larger lipid (1735cm
 1), Amide I
(1624cm
 1) and Amide II (1570, 1516cm
 1) peaks together with a
separate peak at 1681cm
 1 (Amide I) for endometrioid cancers
(see Table 2 for a full list of distinguishing wavenumbers).
Benign tissue vs tumour and tumour-adjacent tissue
Proliferative endometrial tissue was compared with tumour tissue
and its corresponding tumour-adjacent macroscopically normal
tissue (verified as such following microscopic examination of
post-spectroscopy H&E-stained sections). Figure 4A and C show
endometrioid cancer compared with corresponding tumour-
adjacent tissue compared with proliferative tissue for cluster
segregation in the scores plot and discriminating features in the
loadings plot. Likewise, Figure 4B and D show non-endometrioid
cancer compared with corresponding tumour-adjacent tissue
compared with proliferative tissue. The proliferative tissue spectra
used for comparison were the same in both. On histological
examination, the tumour-adjacent tissue was benign and atrophic
in the vast majority of cases (see Table 1).
Figure 4A shows clustering of all three groups and separation
between endometrioid cancer and tumour-adjacent tissue. Here,
the points (representing spectra) from proliferative tissue overlap
with the other two categories, predominantly overlying the
tumour-adjacent tissue plus a small area where all three categories
are present. In contrast, Figure 4B shows less clear separation
between the tumour and tumour-adjacent spectra. On close
inspection, there appears to be two clusters within the non-
endometrioid cancer category. The smaller of these groups is
mingled with the tumour-adjacent and proliferative points and
consists of spectra from two patients with uterine serous
carcinoma. In such pathology, normal-looking cells under micro-
scopy are likely to be at least partially tumourigenic; this approach
in the future might even determine the tumourigenic potential of
adjacent cell populations.
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Figure 3 Comparison of malignant subtypes (endometrioid and non-
endometrioid) with benign endometrial tissue. (A) Scores plot. (B) Cluster
vector plot (benign tissue as comparator).
Table 2 Distinguishing wavenumbers (cm
 1) of endometrioid and non-
endometrioid cancers vs normal benign endometrium with likely originating
bond-type
Endometrioid
cancer (cm
 1)
Non-endometrioid
cancer (cm
 1)
Tentative
assignment
1736 1736 Lipid
1682 Amide I
1624 1624 Amide I
1601 Amide I
1570 1570 Amide II
1516 1516 Amide II
1477 1477 ?Protein
1450 ?Protein
1447 ?Protein
1373 COO-symmetric
stretching
1234 nasPO2
 
1231 nasPO2
 
1173 Carbohydrate
1169 Carbohydrate
1142 C–O stretch (nu CO)
1088 nsPO2
 
1061 1061 nsPO2
 
1034 Glycogen
1003 Glycogen
968 Protein phosphorylation
964 Protein phosphorylation
?¼possibly.
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comparing endometrioid cancer and tumour-adjacent tissue against
proliferative endometrium. The most important wavenumbers in
distinguishing between proliferative endometrium and endometrioid
cancer are 1732cm
 1 (lipid), 1681/1620cm
 1 (both Amide I), 1581/
1516cm
 1 (both Amide II), 1234cm
 1 (nasPO2
 ), 1149cm
 1 (carbo-
hydrate), 1020cm
 1 (glycogen), and 968cm
 1 (protein phosphory-
lation). The differences between proliferative endometrium and
endometrioid tumour-adjacent tissue are much less pronounced.
In Figure 4D, the cluster vectors of non-endometrioid
tumour-adjacent and cancer tissue are compared with normal
proliferative endometrium. Unlike endometrioid cancer and its
tumour-adjacent tissues, these cluster vectors are near-identical,
representing similarity between non-endometrioid cancer and its
corresponding adjacent tissue. The non-endometrioid cancer plot
demonstrates a more pronounced single peak at 1736cm
 1 (lipid
region) and a double peak at 1177 and 1146cm
 1 (?carbohydrate).
The tumour-adjacent tissue has a larger peak at 1030cm
 1 (glycogen).
To strengthen the validity of our findings, all benign tissue
(divided into premenopausal and postmenopausal tissue, all
subtypes) was compared with all tumour-adjacent tissue as
another category; such an examination would lend insight into
the integrity of our tissue sampling and verify our post-spectro-
scopy histological analysis of the tissue sections. For instance, one
would reasonably expect parameters such as myometrial invasion,
blood vessel invasion, and cervical involvement to give rise to a
marked number of outliers in the tumour-adjacent tissue spectral
points in the scores plot. The scores plot in Figure 4E illustrates the
large degree of overlap between the three groups in the absence of
such outliers (particularly so in the tumour-adjacent tissue
cluster), with PCA–LDA essentially unable to separate them. The
premenopausal cluster exhibits the only degree of separation and a
small number of outliers, which is something one might reason-
ably expect as a characteristic of this category. The cluster vector
plot in Figure 4F shows only small differences between the tumour-
adjacent and postmenopausal tissues. The most significant of these
is within the lipid band with a smaller amplitude negative peak
at 1735cm
 1 for tumour-adjacent tissue than for postmenopausal
tissue, whose peak was slightly shifted to 1739cm
 1. As the
majority of tumours studied were from postmenopausal women,
this similarity suggests that the tumour-adjacent tissue is
predominantly biochemically normal or benign.
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Tumours were subclassified according to their histological appear-
ance. Endometrioid cancers were separated by grade and compared
with one another (see Figure 5A and C), and the non-endometrioid
cancers were compared separately (Figure 5B and D). Figure 5A
shows separation between the three grades of endometrioid
endometrial cancer. There are also regions of overlap between each
grade and centrally between all three. Figure 5C compares the cluster
vectors of grade 2 and grade 3 tumours against those of grade 1
tumours. Interestingly and surprisingly, grade 1 tumours appear
more similar to grade 3 tumours than to grade 2. The most notable
peaks in the cluster vector plot for grade 3 tumours are between 1800
and 1450cm
 1, that is, in the lipid region and in Amide I/II.
Figure 5B is a 3D scores plot, thus clustering and separation is
dependent upon rotation. The clustered clear cell spectra separate
clearly along LD1 from the amalgamated clusters of carcinosarcoma,
uterine serous, and mixed spectra. The adenosarcoma spectra are
dispersed between the two groupings. Along LD2, the uterine serous
spectra separate from the carcinosarcoma, adenosarcoma, and clear
cell spectra. LD3 separates the mixed group from all apart from
adenosarcoma. When viewed in 3D, tight clusters are formed by the
clear cell and carcinosarcoma groups. The uterine serous spectra are
more spread out and overlap with the clear cell spectra. The mixed
and adenosarcoma spectra, while still forming clusters, are more
diffuse again and overlap with several other groups. Figure 5D
compares uterine serous against all the other non-endometrioid
tumour types. Adenosarcoma and carcinosarcoma appear alike in
places; they have histological similarities as both contain glandular
and connective tissue elements. Clear cell tumours are the most
different from the other subtypes. Mixed tumours appear to have
the most in common with uterine serous; as they often contain areas
of uterine serous architecture, this is unsurprising.
DISCUSSION
This preliminary study demonstrates that ATR-FTIR spectroscopy
has the potential to distinguish between benign and malig-
nant endometrial tissues, and various subtypes thereof. It also
appears capable of differentiating between normal tissues classified
by phase of the menstrual cycle, although it was not able to
distinguish between menstrual and proliferative tissues. This may
be because the processing technique eliminates any loose surface
shedding endometrium, revealing the very early (biochemically
similar) proliferative tissue beneath. The most conspicuous
differences are within the mid- and late-secretory phases, with a
large accumulation of glycogen in the mid-secretory phase and
rapid change in lipids in the late-secretory phase, together with
structural protein changes indicated by several peaks in the Amide
I/II areas. These changes are likely to be caused by preparation for
the implantation of an embryo.
An important difference between tumour and benign tissue lies
in the lipid area of the spectrum. The lipid absorbance in
endometrioid cancers is greatest in grade 2 and 3 tumours, and
among the non-endometrioid cancers in clear cell tumours,
adenosarcomas and carcinosarcomas. This may represent qualita-
tive or quantitative cell membrane changes. Further differences are
present in the structural protein (Amide I/II) region. These are
larger in endometrioid than non-endometrioid cancers, especially
in Amide I. When tumours are compared with their corresponding
tumour-adjacent tissue, a striking difference is observed between
endometrioid and non-endometrioid cancers. In endometrioid
cancer, the tumour-adjacent tissue almost resembles proliferative
endometrium; in non-endometrioid cancer, it has more features in
common with the adjacent cancer. This may be related to the
pathogenesis of the two tumour types. Endometrioid cancer is
strongly associated with unopposed oestrogen. This will produce
proliferative changes in the non-cancerous adjacent tissue, perhaps
too small to detect with histopathology, but discernable by
spectroscopy.
Small areas of focal intraepithelial carcinoma in tumour-
adjacent tissue could explain its similarity to the corresponding
non-endometrioid tumour. However, Figure 4E suggests a good
degree of clustering of spectral points derived from tumour-
adjacent tissue pointing to this influence being minimal. Unfortu-
nately, it was not possible to confirm this with conventional
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Figure 5 Comparison of grades of endometrioid carcinoma and subtypes of non-endometrioid carcinoma. (A) Endometrioid grades scores plot.
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shistopathology in the current study although all the tissue sections
were H&E-stained and examined by a clinical pathologist post-
spectroscopy. However, significant abnormality in the tumour-
adjacent tissue is unlikely; when benign and tumour-adjacent
tissues were compared, the categories were remarkably similar in
the resultant scores plot (Figure 4E). Endometrioid carcinomas can
be separated by grade, although there is a region of overlap on the
scatter plot. Clear cell tumours are spectrally different from the
rest of the non-endometrioid cancer group. They have a distinctive
molecular signature, which they share with ovarian and renal clear
cell disease (Zorn et al, 2005). It is not known whether they also
share spectral similarities.
As malignant endometrial tissue differs fundamentally from
normal tissue in terms of structure, genetics, and cellular activity,
ATR-FTIR spectroscopy followed by multivariate analysis should
be capable of distinguishing between them. Our data show some
overlap between spectra from different tissue types, potentially
leading to misclassification. The reasons for this are both
methodological and biological. The method of ATR-FTIR spectro-
scopy followed by PCA–LDA described here was initially
developed to distinguish between grades of cervical cytology
(Walsh et al, 2007) and has since been applied successfully to
prostate tissue (Martin et al, 2007). Principal component analysis–
LDA is able to demonstrate data separation and highlight
important wavenumbers; however, in its present form it is
inadequate to predict the pathology of blindly presented samples.
The total number of spectra obtained here (n¼1999) is good for a
preliminary study. When broken down to individual pathological
entities, the numbers are small and the results, while promising,
should be interpreted with caution. Alternative mathematical
models and data processing methods are available and when
combined with large training data sets more successful predictive
models will be developed (Kelly et al, 2010).
The tissue collection and processing methodology was designed
to be simple and reproducible. While it succeeds in this, a major
drawback is that it is impossible to entirely exclude myometrial
contamination. As myometrial spectra are likely to be similar
regardless of the endometrial histological pattern, this could account
for some of the areas of overlap. In future, this could be overcome
by modifying the method of sample collection. Using either a
suction catheter (e.g., Pipelle) or an endometrial brush (e.g., Tao
brush) sampling device would significantly reduce the chance of
harvesting myometrial tissue. It would also allow tissue collection
from women not undergoing hysterectomy and to eliminate the
need for a histopathologist at the point of sample collection.
However, this method could not have been used to compare tumour
with tumour-adjacent tissue as has been demonstrated here.
In a biological context, the fact that perfect segregation of cluster
categories is not observed is unsurprising, as one would expect
some degree of overlap associated with progression or relatedness
of different cell types. This is, in part, because living material is
seldom uniform and endometrial tissue is no exception. Tumour
tissue, especially from a small or low-grade cancer, may contain a
significant proportion of normal cells. In addition, the tissue
examined by the histopathologist may have a different pathological
appearance from the tumour-adjacent tissue used for spectro-
scopy. It has been postulated that some high-grade tumours
develop from low-grade lesions by accumulating oncogenic traits
(Llobet et al, 2009). Tumours may therefore contain a mixed cell
population within the high-grade lesion as it transforms from a
low-grade precursor. The overlapping regions on the scores plots
could be explained by a combination of the above factors.
The current gold standard in determining tumour type and
grade is expert interpretation by a consultant histopathologist.
Because of the complex and subjective nature of the task, opinions
occasionally differ. Biospectroscopy is an emerging discipline that
applies spectroscopic techniques developed by physical chemists
to biological material. Rather than using structural differences,
tissue is analysed at a molecular level and yields objective results.
Such techniques are therefore ideal for gathering data comple-
mentary to the traditional histology described above. The precise
pathological findings are pivotal in planning the treatment of
patients with endometrial cancer and an objective test could have a
valuable supplementary diagnostic role. This technique may be
particularly suitable as a screening technique for endometrial
biopsies, giving a yes/no/maybe to the presence of cancer, thus
determining the need for further investigation. This could prove
useful in resource-poor settings where expert pathological services
are limited.
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